Vaughan, E., Machta, J., Walker, M., Toumpanakis, C., Caplin, M., & Navalkissoor, S. (2018). Retreatment with peptide receptor radionuclide therapy in patients with progressing neuroendocrine tumours: Efficacy and prognostic factors for response. Br J Radiol.
Citación estilo ChicagoVaughan, Emily, Joseph Machta, Martin Walker, Christos Toumpanakis, Martyn Caplin, and Shaunak Navalkissoor. "Retreatment With Peptide Receptor Radionuclide Therapy in Patients With Progressing Neuroendocrine Tumours: Efficacy and Prognostic Factors for Response." Br J Radiol 2018.
Cita MLAVaughan, Emily, et al. "Retreatment With Peptide Receptor Radionuclide Therapy in Patients With Progressing Neuroendocrine Tumours: Efficacy and Prognostic Factors for Response." Br J Radiol 2018.